Allergy News & Research | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Allergy

Lebrikizumab and topical steroids effective in moderate to severe atopic eczema

Lebrikizumab and topical steroids effective in moderate to severe atopic eczema

Early emollient use among high-risk infants prevents atopic eczema

Early emollient use among high-risk infants prevents atopic eczema

Meet the Expert: Focus on HAE

Meet the Expert: Focus on HAE

Different emollient formulations appear to be equally effective in childhood eczema

Different emollient formulations appear to be equally effective in childhood eczema

Probiotic mixture reduces wheezing in preschool children

Probiotic mixture reduces wheezing in preschool children

Older adults with atopic eczema at greater risk of developing Alzheimer’s disease

Older adults with atopic eczema at greater risk of developing Alzheimer’s disease

$Lirentelimab effective for refractory chronic urticaria$

Lirentelimab effective for refractory chronic urticaria

Peanut allergy leads to huge psychosocial burden among sufferers

Peanut allergy leads to huge psychosocial burden among sufferers

Peanut oral immunotherapy increases desensitisation and remission in children

Peanut oral immunotherapy increases desensitisation and remission in children

Add-on dupilumab therapy reduces exacerbations in children with moderate-to-severe asthma

Add-on dupilumab therapy reduces exacerbations in children with moderate-to-severe asthma

Dupilumab reduces COVID-19 symptom burden in patients with atopic eczema

Dupilumab reduces COVID-19 symptom burden in patients with atopic eczema

Allergen immunotherapy effectiveness confirmed in long-term real-world study

Allergen immunotherapy effectiveness confirmed in long-term real-world study